Literature DB >> 25700258

[Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists: The anti-VEGF therapy in neovascular age-related macular degeneration: Therapeutic Strategies (November 2014)].

Deutsche Ophthalmologische Gesellschaft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25700258     DOI： 10.1055/s-0034-1396162

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN： 0023-2165            Impact factor:   0.700


× No keyword cloud information.
  9 in total

1.  [Long-term results in neovascular age-related macular degeneration : Changes in visual acuity and geographic atrophy during long-standing anti-VEGF therapy].

Authors:  V Thalgott; N Feucht; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

Review 2.  [IVOM quality assurance in Westfalen-Lippe : Structure of quality assurance and results of the pilot study Q-VERA].

Authors:  J Stasch-Bouws; S M Eller-Woywod; S Schmickler; J Inderfurth; P Hoffmann; C Ohlmeyer; B Kammering; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

3.  [Clinical parameters of patients with neovascular age-related macular degeneration : Longterm treatment results of an outpatient clinic].

Authors:  S Wassel; E Tsompanidi; E Tahmaz; B Hörster; R Hoerster
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

4.  [Visual acuity in anti-VEGF therapy for AMD : Can specific characteristics in the SD-OCT help?]

Authors:  B Book; M Ziegler; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

5.  [Tear in the retinal pigment epithelium by intravitreal injection of aflibercept].

Authors:  T Bertelmann; W Sekundo; Y Wenner
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

6.  Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up.

Authors:  Nadezhda P Cvetkova; Kristina Hölldobler; Philipp Prahs; Viola Radeck; Horst Helbig; David Märker
Journal:  Clin Ophthalmol       Date:  2016-06-08

7.  Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex.

Authors:  Mahdy Ranjbar; Maximilian Kurz; Annekatrin Holzhey; Corinna Melchert; Dirk Rades; Salvatore Grisanti
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research.

Authors:  Armin Wolf; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-15       Impact factor: 3.117

9.  Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration-12-month post hoc analysis of the PERSEUS real-world evidence study.

Authors:  Joachim Wachtlin; Nicole Eter; Zoran Hasanbasic; Georgios Keramas; Christine Rech; Helmut Sachs; Harald Schilling; Peter Wiedemann; Carsten Framme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-13       Impact factor: 3.117
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.